Standard BioTools Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	86.26	85.33	91.01	106.34	97.95	130.58
Revenue Growth (YoY)	-3.71%	-6.24%	-14.42%	8.57%	-24.99%	-5.47%
Cost of Revenue	43.45	42.79	46.13	55.89	60.9	61.21
Gross Profit	42.8	42.54	44.88	50.45	37.05	69.37
Selling, General & Admin	98.64	109.86	103.06	87.54	102.29	98.89
Research & Development	22.66	25.99	28.83	25.95	37.38	37.94
Other Operating Expenses	17.27	16.94	40.48	13.56	13.59	-
Total Operating Expenses	138.58	152.79	172.37	127.05	153.26	136.83
Operating Income	-95.78	-110.25	-127.49	-76.6	-116.21	-67.46
Interest Income	3.51	9.18	20.2	5.57	2.23	7.14
Interest Expense	-	-0.03	-3.32	-4.57	-4.33	-3.82
Other Non-Operating Income (Expense)	-1.8	4.39	20.21	1.39	-74.62	0.48
Total Non-Operating Income (Expense)	1.71	13.55	37.09	2.4	-76.72	3.8
Pretax Income	-94.07	-96.7	-90.4	-74.2	-192.93	-63.66
Provision for Income Taxes	-37.75	-37.88	0.54	0.45	-2.83	-4.42
Net Income	78.21	-74.9	-138.89	-74.66	-190.1	-59.24
Earnings From Discontinued Operations	128.29	-16.07	-47.95	-	-	-
Net Income to Common	78.21	-149.79	-46.01	-149.31	-380.2	-59.24
Shares Outstanding (Basic)	384	382	353	79	78	78
Shares Outstanding (Diluted)	384	382	353	79	78	78
Shares Change (YoY)	2.66%	8.03%	346.24%	1.09%	-	8.69%
EPS (Basic)	0.20	-0.20	-0.52	-0.94	-2.43	-0.64
EPS (Diluted)	0.20	-0.20	-0.52	-0.94	-2.43	-0.64
Free Cash Flow	-94.48	-82.65	-151.81	-46.12	-93.2	-57.33
Free Cash Flow Per Share	-0.25	-0.22	-0.43	-0.58	-1.19	-0.73
Gross Margin	49.62%	49.86%	49.32%	47.44%	37.83%	53.13%
Operating Margin	-111.04%	-129.20%	-140.08%	-72.03%	-118.64%	-51.66%
Profit Margin	90.67%	-87.77%	-152.61%	-70.20%	-194.08%	-45.36%
FCF Margin	-109.53%	-96.85%	-166.81%	-43.37%	-95.15%	-43.90%
EBITDA	-87.56	-99.27	-110.62	-61.42	-101.18	-51.89
EBITDA Margin	-101.51%	-116.34%	-121.55%	-57.76%	-103.30%	-39.74%
EBIT	-95.78	-110.25	-127.49	-76.6	-116.21	-67.46
EBIT Margin	-111.04%	-129.20%	-140.08%	-72.03%	-118.64%	-51.66%
Effective Tax Rate	40.13%	39.17%	-0.60%	-0.61%	1.47%	6.95%

SEC Filings: 10-K · 10-Q